Market Cap
$17.18B$64.09M-0.37%
Summary
- Current Value
- As of today, RPRX market cap is $17B, down -0.37% in the most recent trading session on
- Category
- Based on its current market cap, RPRX falls into the large-cap category
- Historical Performance
- RPRX market cap is up +4.06% year-to-date, and up +28.27% over the past 365 days
- All-Time High Comparison
- RPRX market cap is currently -16.20% below its historical high of $21B set on
- 3-Year Low Comparison
- RPRX market cap is +59.25% above its 3-year low of $11B reached on
- Sector Comparison
- RPRX market cap is higher than 93.98% of companies in Healthcare sector
Market Cap Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $17B | -0.4% | +4.7% | +11.2% | +4.1% | +28.3% | -1.5% | -13.6% | |
| Price | $40.21 | -0.4% | +4.7% | +11.7% | +4.1% | +33.9% | +2.1% | -21.5% | |
| Shares Outstanding | 427.25M | -0.4% | – | – | – | -4.2% | -3.6% | +10.1% | |
| PE Ratio | 22.99 | -0.4% | +4.7% | +11.7% | +4.0% | +46.8% | -93.4% | +18.0% | |
| TTM Revenue | $2.35B | +1.9% | – | +1.9% | – | +3.7% | +4.6% | +17.1% | |
| TTM EPS | $1.75 | -23.9% | – | -23.9% | – | -31.6% | +50.7% | -71.2% | |
| Enterprise Value | $25.19B | -0.3% | +3.2% | +7.4% | +2.7% | +25.8% | +10.3% | +6.5% | |
| TTM Dividend Per Share | $0.88 | 0.0% | 0.0% | +1.1% | 0.0% | +4.8% | +15.8% | +193.3% | |
| TTM Net Income | $1.30B | -21.8% | – | -21.8% | – | -24.0% | +45.6% | -53.2% |
Market Cap Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | $18B | -2.9% | |
| 3M | $18B | -2.9% | |
| 6M | $18B | -2.9% | |
| 1Y | $18B | -2.9% | |
| 3Y | $18B | -2.9% | |
| 5Y | $21B | -16.2% | |
| All | $21B | -16.2% |
Market Cap Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | $16B | +5.0% | |
| 3M | $15B | +11.2% | |
| 6M | $15B | +13.9% | |
| 1Y | $13B | +30.9% | |
| 3Y | $11B | +59.3% | |
| 5Y | $11B | +59.3% | |
| All | $11B | +59.3% |
Market Cap History
| Date | Value | Change |
|---|---|---|
| $17B | +4.1% | |
| $17B | +45.1% | |
| $11B | -9.3% | |
| $13B | -28.4% |
| Date | Value | Change |
|---|---|---|
| $18B | +1.5% | |
| $17B | -11.2% | |
| $19B | - |
FAQ
What is the current market cap of RPRX?
As of today, RPRX market cap is $17B
What market cap category does RPRX fall into?
Based on its current market cap, RPRX falls into the large-cap category
What is RPRX market cap today change?
RPRX market cap is down -0.37% today
What is 1-year change in RPRX market cap?
RPRX market cap is up +28.27% year-over-year
How far is RPRX market cap from its all-time high?
RPRX market cap is currently -16.20% below its historical high of $21B set on January 26, 2021
How does RPRX market cap rank versus sector peers?
RPRX market cap is higher than 93.98% of companies in Healthcare sector
Market Cap Formula
Market Cap = Price × Shares Outstanding
Data Sources & References
- RPRX Official Website www.royaltypharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1802768/000180276825000114/0001802768-25-000114-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802768/000180276825000010/0001802768-25-000010-index.htm
- RPRX Profile on Yahoo Finance finance.yahoo.com/quote/RPRX
- RPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rprx